Stocksigma LogoStocksigma Logo

US FDA Concludes Unit-IV Inspection of Aurobindo Pharma Subsidiary with Zero Observations

The US FDA inspected Unit-IV, an API manufacturing facility of Aurobindo Pharma's wholly owned subsidiary, Apitoria Pharma Private Limited, located at

US FDA Concludes Unit-IV Inspection of Aurobindo Pharma Subsidiary with Zero Observations

Aurobindo Pharma Ltd 路 Others (Uncategorized) 路 11 Sept 2026, 11:04 pm

US FDA Concludes Unit-IV Inspection of Aurobindo Pharma Subsidiary with Zero Observations The US FDA inspected Unit-IV, an API manufacturing facility of Aurobindo Pharma's wholly owned subsidiary, Apitoria Pharma Private Limited, located at Pydibhimavaram, Srikakulam District, Andhra Pradesh. Conducted from 7th Sep'26 to 11th Sep'26, the regulatory audit concluded successfully with zero observations, underscoring the facility's compliance with robust quality and manufacturing standards.

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements